Skip to content
Sora Lifesciences
GTM

Distributor vs. direct: choosing a market-entry model for MedTech

The right entry model depends on more than margin. A framework for weighing distributor coverage, control, and speed against a direct commercial build.

Feb 18, 2026

Selecting the right local partner is often the single biggest determinant of a market-expansion strategy's success. But distributor-led entry trades control for speed and coverage.

We compare distributor, hybrid, and direct models across control, cost, regulatory burden, and time-to-revenue — and outline how structured distributor matchmaking de-risks the decision.

Get in touch

Want to talk this through?

Tell us what decision you're facing. We'll turn it into a clear, evidence-backed answer.

© 2026 Sora Life Sciences. All rights reserved.